Clinuvel Pharmaceuticals
CUV.AX
#7968
Rank
S$0.47 B
Marketcap
S$9.32
Share price
3.73%
Change (1 day)
15.80%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2025: S$43.75 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are S$62.5 Million. In 2025 the company made an earning of S$43.75 Million, an increase over its 2024 earnings that were of S$43.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025S$43.75 M0.26%
2024S$43.64 M11.35%
2023S$39.19 M28.31%
2022S$30.54 M22.8%
2021S$24.87 M112.63%
2020S$11.69 M-28.73%
2019S$16.41 M32.79%
2018S$12.36 M75.41%
2017S$7.04 M-332.52%
2016-S$3.04 Million-70.68%
2015-S$10.34 Million53.78%
2014-S$6.73 Million-16.1%
2013-S$8.02 Million-37.92%
2012-S$12.91 Million-18.19%
2011-S$15.78 Million25.31%
2010-S$12.6 Million-21.53%
2009-S$16.05 Million-11.27%
2008-S$18.09 Million80.4%
2007-S$10.03 Million-2.46%
2006-S$10.28 Million-5.35%
2005-S$10.86 Million60.55%
2004-S$6.77 Million97.37%
2003-S$3.43 Million50.62%
2002-S$2.28 Million121.22%
2001-S$1.03 Million254.48%
2000-S$0.3 Million